In one paragraphArticle in Microbiology spectrum, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
9 authors.
Marcus de M TeixeiraNúcleo de Medicina Tropical, Faculdade de Medicina, Universidade de Brasília, Brasília, Brazil.ORCID 0000-0003-1763-3464 Sarah A AhmedDepartment of Microbiology, College of Medicine, Kuwait University, Kuwait City, Kuwait.ORCID 0000-0003-0155-8113 Jason E StajichDepartment of Microbiology & Plant Pathology, Institute for Integrative Genome Biology, University of California, Riverside, California, USA.ORCID 0000-0002-7591-0020 Daniel R MatuteDepartment of Biology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.ORCID 0000-0002-7597-602X George R ThompsonDepartment of Medicine/Division of Infectious Diseases and Medical Microbiology and Immunology, University of California Davis, Davis, California, USA.ORCID 0000-0001-8518-5750 Bridget M BarkerThe Pathogen and Microbiome Institute, Northern Arizona University, Flagstaff, Arizona, USA.ORCID 0000-0002-3439-4517 Funding
Early in vivo Expressed Antigens and their Role in Virulence, Immune Response, and Vaccines for CoccidioidomycosisU19AI166058 · NIAID · NORTHERN ARIZONA UNIVERSITY · PI Deborah H. Fuller · 2022 to 2026
$12.1MVirulence gene discovery in CoccidioidesU19AI166798 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Satya Dandekar · 2022 to 2026
$10.5MThe evolution of virulence in the fungal pathogen HistoplasmaR01AI153523 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI MATUTE, DANIEL · 2021 to 2025
$3.2MNovel antifungal agents against coccidioidomycosisR01AI175635 · NIAID · UNIVERSITY OF COLORADO · PI Maciej Walczak · 2024 to 2026
$2.2MRegulation of infectious spore formation in the fungal pathogen Coccidioides posadasiiR21AI193607 · NIAID · UNIVERSITY OF CALIFORNIA BERKELEY · PI BREM, RACHEL BETH · 2025 to 2025
$438kNational Institute of Allergy and Infectious Diseases U19AI166058National Institute of Allergy and Infectious Diseases U19AI166798NIAID NIH HHS R01 AI153523NIAID NIH HHS R01 AI175635NIAID NIH HHS R21 AI193607NIAID NIH HHS U19 AI166058NIAID NIH HHS U19 AI166798
6 · The paper itselfAbstract
IMPORTANCE: Accurate identification and characterization of emerging fungal pathogens are essential for improving diagnosis and treatment.
Indexed as
CoccidioidesCoccidioidomycosisHypocrealesAntifungal AgentsGenome, FungalHumansPhylogenyAntifungal Agentsantifungal resistanceCoccidioides posadasiicomparative genomicsfungal pathogensmicrobial interactionsopportunistic infectionsSarocladium spinificis
Identifiers
PMID41459970
PMCPMC12889048
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390